Andrew A. Nierenberg, MD

Original Research

Complicated Grief and Its Correlates in Patients With Bipolar Disorder

September 15, 2005

Naomi M. Simon, Mark H. Pollack, Diana Fischmann, et al

Original Research

Clinical and Demographic Features of Atypical Depression in Outpatients With Major Depressive Disorder: Preliminary Findings From STAR*D.

August 15, 2005

Jon S. Novick, Jonathan W. Stewart, Stephen R. Wisniewski, et al

Original Research

An Open Study of Triiodothyronine Augmentation of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Major Depressive Disorder

August 15, 2005

Dan V. Iosifescu, Andrew A. Nierenberg, David Mischoulon, et al

Original Research

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

June 15, 2005

Roger D. Weiss, Michael J. Ostacher, Michael W. Otto, et al

Original Research

Psychotherapy and Medication in the Treatment of Adult and Geriatric Depression: Which Monotherapy or Combined Treatment?

April 15, 2005

Steven D. Hollon, Robin B. Jarrett, Andrew A. Nierenberg, et al

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

August 16, 2004

George I. Papakostas, Timothy Petersen, David Mischoulon, et al

Original Research

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

August 16, 2004

George I. Papakostas, Timothy Petersen, David Mischoulon, et al

Original Research

Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder

April 1, 2004

George I. Papakostas, Timothy J. Petersen, Dan V. Iosifescu, et al

Original Research

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

February 1, 2004

George I. Papakostas, Timothy J. Petersen, Andrew A. Nierenberg, et al

Original Research

Psychiatric Comorbidity as a Predictor of Clinical Response to Nortriptyline in Treatment-Resistant Major Depressive Disorder

November 15, 2003

Timothy J. Petersen, Amy H. Farabaugh, Jessica L. Murakami, et al

DELETE Current Perspectives in the Treatment of Depression

Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy

October 1, 2003

Andrew A. Nierenberg, Timothy J. Petersen, Jonathan E. Alpert

DELETE Current Perspectives in the Treatment of Depression

Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy

October 1, 2003

Andrew A. Nierenberg, Timothy J. Petersen, Jonathan E. Alpert

Complicated Grief and Its Correlates in Patients With Bipolar Disorder

Clinical and Demographic Features of Atypical Depression in Outpatients With Major Depressive Disorder: Preliminary Findings From STAR*D.

An Open Study of Triiodothyronine Augmentation of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Major Depressive Disorder

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

Psychotherapy and Medication in the Treatment of Adult and Geriatric Depression: Which Monotherapy or Combined Treatment?

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

Psychiatric Comorbidity as a Predictor of Clinical Response to Nortriptyline in Treatment-Resistant Major Depressive Disorder

Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy

Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy

ELSEWHERE:

FOLLOW US:

Andrew A. Nierenberg, MD

Complicated Grief and Its Correlates in Patients With Bipolar Disorder

Clinical and Demographic Features of Atypical Depression in Outpatients With Major Depressive Disorder: Preliminary Findings From STAR*D.

An Open Study of Triiodothyronine Augmentation of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Major Depressive Disorder

Does Recovery From Substance Use Disorder Matter in Patients With Bipolar Disorder?

Psychotherapy and Medication in the Treatment of Adult and Geriatric Depression: Which Monotherapy or Combined Treatment?

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy

Somatic Symptoms as Predictors of Time to Onset of Response to Fluoxetine in Major Depressive Disorder

Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder

Psychiatric Comorbidity as a Predictor of Clinical Response to Nortriptyline in Treatment-Resistant Major Depressive Disorder

Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy

Prevention of Relapse and Recurrence in Depression: The Role of Long-Term Pharmacotherapy and Psychotherapy

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles